KMT2A and acute myeloid leukemia: There was also no apparent correlation between the expression of Chondroitin Sulfate Proteoglycan 4 (CSPG4) on AML blasts and the presence of KMT2A rearrangement, which clearly indicates that CSPG4 cannot be regarded as a substitute marker for this rearrangement [10].